tirzepatide is a glp (GLP-1/GIP) - 15mg FDA approval for Zepbound (tirzepatide)

Duodenum Glandular Concentrate (99mg) Duodenum tissue concentrate provides tissue-specific factors from the first segment of the small intestine where bile and pancreatic enzymes enter the gut for fat and protein digestion supporting normal small intestinal digestive function.*

GLP-1 receptor agonists reduce dementia and Alzheimer disease risk in diabetic patients with CKD

GLP - 1 drugs represented by tirzepatide not only show the potential to become the "drug of the year", but also activate the investment boom in the entire GLP - 1 industry chain, and relevant investment opportunities have thus emerged

The same cortico-basal ganglia-thalamic-cortical circuitry was impacted highlighting the sensitivity of these brain regions to PEA

Whens the best time to take it

Novo) #HealthcareGovernance #BoardOversight #GLP1 #Obesity #Retatrutide #EliLilly #Pharma #NACD